Zepbound 7.5 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FJ2LY
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,691
Award facts
- Contract value 100% obligated
- $19,691.34 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on June 20, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pens (semaglutide injection) with a ceiling value of $19,691.34 and an ultimate completion date of June 23, 2025. This is a firm fixed-price delivery order placed under a non-set-aside competitive procurement, with performance conducted at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a continuation of the vendor's ongoing role as a critical pharmaceutical supplier to the federal government's military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen's demonstrated capability to fulfill federal medical procurement requirements through open competition, evidenced by its extensive portfolio of pharmaceutical and medical device deliveries, positions it as a primary vendor within DLA's Pharmaceutical Prime Vendor Global Program.
Quick answers
Who was awarded contract SPE2DB25FJ2LY?
SPE2DB25FJ2LY was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 20, 2025.
How much is contract SPE2DB25FJ2LY worth?
The government has obligated $19,691 on SPE2DB25FJ2LY.
Is contract SPE2DB25FJ2LY an order under another contract?
Yes. SPE2DB25FJ2LY is a delivery order under SPE2DB22D2007, an indefinite delivery contract.
Was contract SPE2DB25FJ2LY competed?
The extent of competition for SPE2DB25FJ2LY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award